Skip to content

Evaluation of Malva Sylvestris. formulation on Radiation proctitis

Clinical Trial of malva Sylvestris L. formulation on intestinal side effects of pelvic cancers radiation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012101011064N1
Enrollment
40
Registered
2014-04-19
Start date
2013-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation proctitis. Radiation proctitis

Interventions

Intervention 1: In the intervention group patient should use sachet of Malva, 12 mg in 3 dosage that should brewed in boiled water, from first day of radiation until end of that.(each pocket is 4 g).
Prevention
Placebo
In the intervention group patient should use sachet of Malva, 12 mg in 3 dosage that should brewed in boiled water, from first day of radiation until end of that.(each pocket is 4 g)
All patients in control group take powder of placebo which is designed for this study in 4 mg packets in three dosages a day orally with a glass of hot water.

Sponsors

Vice chancellor for education, faculty of ?Traditional Medicine, Tehran university
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients who are planed pelvic radiotherapy with impression of cancer Age over 18 years; Non Inclusion criteria: Other natural therapy during the study; Thrombotic diseases; Known gastrointestinal disease before radiotherapy; severe Cardiovascular disease; uncontrolled Diabetes; severe Hypertension; Severe cognitive impairment; Psychotic disorder

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anal Burning. Timepoint: Every 3 weeks. Method of measurement: visual analog scale 0-10.;Diarrhea. Timepoint: every 3 week. Method of measurement: visual analog scale 0-10.;Fecal incontinence. Timepoint: every 3 weeks. Method of measurement: visual analog scale.;Fecal urgency. Timepoint: every 3 weeks. Method of measurement: visual analog scale.;Anal bleeding. Timepoint: every 3 weeks. Method of measurement: visual analog scale.;Excretion of mucous. Timepoint: every 3 weeks. Method of measurement: visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReihaneh Moeini

Faculty of Traditional Medicine, Tehran university of medical science

rhei_mo@yahoo.com+98 912 606 5380

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026